Announcements Trials

Browse Landscape

Phase

Status

Completed 4 Unknown 1 Suspended 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Polycythemia Vera 2 Leukemia, Myeloid, Acute 2 Treatment-Refractory Solid Tumors 1 Squamous Cell Carcinoma of Head and Neck 1 Myelodysplastic Syndromes 1 Meningioma 1 Leukemia, Myelomonocytic, Chronic 1 Head and Neck Neoplasms 1 HPV-Negative Squamous Cell Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 6 lutetium Lu 177 dotatate 4 Specimen Handling 4 Proton Therapy 3 Bevacizumab 3 gallium Ga 68 dotatate 2 abemaciclib 2 Protons 2 Observation 2 Ga(III)-DOTATOC 2 Everolimus 2 Elasticity Imaging Techniques 2 trametinib 1 regorafenib 1 pembrolizumab 1 olaparib 1 neratinib 1 fludarabine 1 dexamethasone acetate 1 dexamethasone 21-phosphate 1 capivasertib 1 cabozantinib 1 brigatinib 1 auricularum 1 apatinib 1 X-Rays 1 Watchful Waiting 1 Thrombectomy 1 Tablets 1 Surveys and Questionnaires 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Meningioma × Hydroxyurea × Clear all

NCT06326190 2025-09-16

LUMEN-1

European Organisation for Research and Treatment of Cancer - EORTC

Phase 2 Recruiting

Meningioma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡